Steve O'Loughlin
Director of Finance/CFO at ACTINIUM PHARMACEUTICALS, INC.
Net worth: 9 263 $ as of 2024-03-30
Profile
Steve O'Loughlin is currently the Chief Financial & Accounting Officer at Actinium Pharmaceuticals, Inc. Prior to this, he was the Vice President-Corporate Finance & Development at Protea Biosciences Group, Inc. from 2012 to 2015.
He completed his undergraduate degree at Ramapo College of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-12-27 | 1,183 ( 0.00% ) | 9 263 $ | 2024-03-30 |
Steve O'Loughlin active positions
| Companies | Position | Start |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2017-05-14 |
Former positions of Steve O'Loughlin
| Companies | Position | End |
|---|---|---|
| PROTEA BIOSCIENCES GROUP, INC | Corporate Officer/Principal | 2015-05-31 |
Training of Steve O'Loughlin
| Ramapo College of New Jersey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
- Stock Market
- Insiders
- Steve O'Loughlin
